Overview
Rongjia Su practices practicing medicine in Shanghai, China.
Their clinical expertise encompasses Ovarian Cancer, Cervical Cancer, Anal Cancer, Endometrial Cancer, and Hysterectomy.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rongjia Su
Is Rongjia Su a top-rated expert for Ovarian Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Rongjia Su is classified as an Experienced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rongjia Su participate in research or clinical trials?
Yes. Rongjia Su has published 12 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Rongjia Su's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Anal CancerSu isExperienced. Learn about Anal Cancer.
- Cervical CancerSu isExperienced. Learn about Cervical Cancer.
- Endometrial CancerSu isExperienced. Learn about Endometrial Cancer.
- HysterectomySu isExperienced. Learn about Hysterectomy.
- Ovarian CancerSu isExperienced. Learn about Ovarian Cancer.